Published in J Hepatol on October 26, 2008
A New Screening Strategy for Varices (LSSM-RCT) | NCT02024347
Hepatitis C. Lancet (2015) 1.95
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol (2014) 1.20
Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int (2011) 1.15
Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med (2010) 1.13
Clinical applications of transient elastography. Clin Mol Hepatol (2012) 1.07
Non-invasive assessment of liver fibrosis. Ann Gastroenterol (2012) 1.07
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol (2014) 1.05
Transient elastography: Kill two birds with one stone? World J Hepatol (2013) 1.03
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol (2013) 1.02
Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol (2009) 1.02
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci (2010) 0.99
Transient elastography for predicting esophageal/gastric varices in children with biliary atresia. BMC Gastroenterol (2011) 0.94
Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS One (2013) 0.94
Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique. Radiology (2014) 0.92
Chronic hepatitis C and liver fibrosis. World J Gastroenterol (2014) 0.92
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients. World J Hepatol (2014) 0.91
Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci (2012) 0.90
Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) (2013) 0.90
Value of transient elastography for the prediction of variceal bleeding. World J Gastroenterol (2011) 0.90
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.90
Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol (2014) 0.89
Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study. Gastroenterol Res Pract (2015) 0.89
Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease? Hepat Mon (2011) 0.88
Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol (2015) 0.87
Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol (2013) 0.87
Noninvasive evaluation of portal hypertension: emerging tools and techniques. Int J Hepatol (2012) 0.86
The use of transient elastography in the management of chronic hepatitis B. Hepatol Int (2011) 0.85
Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol (2012) 0.84
Liver stiffness measurement by fibroscan predicts the presence and size of esophageal varices in egyptian patients with HCV related liver cirrhosis. J Clin Diagn Res (2013) 0.84
Possible patient early diagnosis by ultrasonic noninvasive estimation of thermal gradients into tissues based on spectral changes modeling. Comput Math Methods Med (2012) 0.84
Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome. PLoS One (2013) 0.82
Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int (2010) 0.81
A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. PLoS One (2014) 0.80
Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Int J Endocrinol (2015) 0.80
Estimation of PSD shifts for high-resolution metrology of thickness micro-changes with possible applications in vessel walls and biological membrane characterization. Sensors (Basel) (2012) 0.79
Liver ultrasound elastography: More than staging the disease. World J Hepatol (2015) 0.78
Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol (2014) 0.78
Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics. World J Gastroenterol (2015) 0.78
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis. BMC Infect Dis (2015) 0.77
Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther (2016) 0.77
Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care. J Natl Cancer Inst (2015) 0.77
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol (2016) 0.76
Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection. J Hepatol (2008) 0.76
Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? Front Pharmacol (2016) 0.76
Ultrasonographic elastometry vs. blood tests for the diagnosis of cirrhosis: a Pyrrhic victory? J Hepatol (2009) 0.75
Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75
Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A meta-analysis. World J Gastroenterol (2017) 0.75
Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol (2016) 0.75
A Beginning or the End? A Meta-analysis to Assess the Diagnostic Accuracy of Transient Elastography for the Prediction of Esophageal Varices. Saudi J Gastroenterol (2016) 0.75
Assessment of risk of complications in cirrhosis using portal thallium scans. World J Gastroenterol (2014) 0.75
The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients. Medicine (Baltimore) (2015) 0.75
The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease. Gastroenterol Rep (Oxf) (2014) 0.75
Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C. Open Forum Infect Dis (2016) 0.75
Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India. Open Forum Infect Dis (2016) 0.75
Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol (2017) 0.75
Real-time elastography as a noninvasive assessment of liver fibrosis in chronic hepatitis C Egyptian patients: a prospective study. Ann Gastroenterol (2016) 0.75
Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension? Clin Mol Hepatol (2017) 0.75
Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and Opinion. J Clin Transl Hepatol (2014) 0.75
Elastography for hepatic fibrosis severity in chronic hepatitis B or C. Case Rep Gastroenterol (2011) 0.75
Current role of transient elastography in the management of chronic hepatitis B patients. Ultrasonography (2016) 0.75
Evolving strategies for liver fibrosis staging: Non-invasive assessment. World J Gastroenterol (2017) 0.75
Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study. PLoS One (2017) 0.75
Ultrasonography for Noninvasive Assessment of Portal Hypertension. Gut Liver (2017) 0.75
Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) (2017) 0.75
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology (2005) 9.44
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology (2005) 5.93
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol (2013) 5.64
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology (2007) 3.75
Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol (2006) 3.57
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology (2010) 3.22
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology (2010) 2.58
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology (2002) 2.56
Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology (2011) 2.54
Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol (2006) 2.37
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology (2005) 2.33
[Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol (2002) 2.22
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology (2006) 2.21
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology (2009) 2.20
Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int (2008) 2.19
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology (2006) 2.07
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology (2007) 1.94
Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys (2009) 1.87
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.86
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86
Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum (2011) 1.82
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol (2011) 1.79
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int (2012) 1.71
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. Blood (2011) 1.71
Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg (2013) 1.68
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int (2008) 1.62
Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis (2003) 1.59
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Relationship between ventilatory settings and barotrauma in the acute respiratory distress syndrome. Intensive Care Med (2002) 1.57
Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C. Gut (2010) 1.55
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology (2009) 1.55
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology (2005) 1.52
Revision total hip arthroplasty performed after fracture of a ceramic femoral head. A multicenter survivorship study. J Bone Joint Surg Am (2003) 1.52
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? AIDS (2002) 1.50
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily. J Hepatol (2007) 1.49
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal. Clin Transplant (2002) 1.48
Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr (2007) 1.47
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.47
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J Clin Psychiatry (2005) 1.41
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma. Liver Int (2009) 1.40
On the validity of meta-analyses: exhaustivity must be warranted, exclusion of duplicate patients too. J Clin Epidemiol (2010) 1.39
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol (2011) 1.32
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl (2005) 1.28
Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med (2008) 1.28
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol (2012) 1.26
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol (2006) 1.25
Real-time monitoring of radiofrequency ablation of rabbit liver by respiratory-gated quantitative temperature MRI. J Magn Reson Imaging (2006) 1.22
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol (2009) 1.18
Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med (2003) 1.17
Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol (2011) 1.17
Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int (2010) 1.16
Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion (2006) 1.14
Patterns of mortality in sickle cell disease in adults in France and England. Hematol J (2002) 1.12
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France. J Med Virol (2010) 1.11
Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant (2005) 1.11
The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med (2003) 1.09
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol (2008) 1.09
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation. Sci Transl Med (2010) 1.08
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease. Radiology (2013) 1.07
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study. Br J Haematol (2014) 1.05
Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica (2012) 1.03
Computer-assisted analysis helps detect inner dynein arm abnormalities. Am J Respir Crit Care Med (2002) 1.02